Aims: In the HORIZONS-AMI trial, bivalirudin compared to unfractionated heparin (UFH) plus a glycoprotein IIb/IIIa inhibitor (GPI) improved net clinical outcomes in patients undergoing pr
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com